"Antisense Oncogene and Tumor Suppressor Gene Therapy of Cancer."

According to the author's abstract of an article published in Journal of Molecular Medicine - Jmm, "Rapid advances in cancer gene therapy are driven by an explosive development of gene transfer technology and a strong demand for seeking alternatives to unsatisfactory conventional cancer therapies. Discovery of the genetic basis of cancer has indicated that cancer is a disease of genes. Among a variety of approaches to gene therapy of cancer, antisense oncogene and tumor suppressor gene therapy of cancer are the two strategies that aim at correcting genetic disorders of cancer through suppression of the abnormal expression of the proliferative genes. The potential effectiveness of these...

Want to see the full article?

• Purchase this article for only $3.00